AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,310.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.66m
  • Volume: 167,225
  • Market Cap: £159,873m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca's Datroway gets green light from FDA

By Iain Gilbert

Date: Tuesday 24 Jun 2025

(Sharecast News) - Drugmaker AstraZeneca's Datroway has been approved in the US for adult patients with previously treated advanced EGFR-mutated non-small cell lung cancer.

AstraZeneca ShareCast News

AstraZeneca launches strategic research collabor... 13-Jun-2025 ShareCast
AstraZeneca's Calquence receives European Commis... 06-Jun-2025 ShareCast
EU recommends AstraZeneca bladder cancer treatme... 27-May-2025 ShareCast
London close: Stocks finish choppy week in the b... 16-May-2025 ShareCast
London close: Stocks rally on US-China tariff deal 12-May-2025 ShareCast

AstraZeneca Regulatory News

Datroway approved in US for EGFRm lung cancer 24-Jun-2025 07:00 RNS
Holding(s) in Company 17-Jun-2025 11:45 RNS
AstraZeneca enters into collaboration with CSPC 13-Jun-2025 09:30 RNS
Director/PDMR Shareholding 12-Jun-2025 15:00 RNS
Fixed-duration Calquence approved in EU for 1L CLL 06-Jun-2025 07:00 RNS

AstraZeneca Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,310.00p
Change Today -22.00p
% Change -0.21 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 167,225
Shares Issued 1,550.66m
Market Cap £159,873m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94% below the market average94% below the market average94% below the market average94% below the market average94% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Price Trend
38.62% below the market average38.62% below the market average38.62% below the market average38.62% below the market average38.62% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
60.66% below the market average60.66% below the market average60.66% below the market average60.66% below the market average60.66% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.62% above the market average86.62% above the market average86.62% above the market average86.62% above the market average86.62% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 25-Jun-2025

Time Volume / Share Price
13:30 0 @ 10,306.00p
13:30 50 @ 10,310.00p
13:29 110 @ 10,310.00p
13:29 1 @ 10,314.00p
13:29 12 @ 10,313.56p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page